Amplifon Stock - analyst consensus and earnings outlook
22.06.2026 - 14:26:58 | ad-hoc-news.de
Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 14:26 CET. Details in the imprint.
Amplifon (IT0004056880) is a leading global hearing-care retailer listed in Milan. With no fresh company announcement from Investor Relations or major newswires in the past day, the focus turns to the stock's earnings calendar and analyst expectations for the coming quarters.
All news and data on Amplifon stock
Key company announcements, regulatory filings and price data for Amplifon stock are collected on the dedicated topic page and the official Investor Relations site.
What recent numbers show
Amplifon reported full-year 2024 results on 02/27/2025, posting consolidated revenues of about EUR 2.43 billion, up roughly 7% year-on-year, with EBITDA margin broadly stable according to the company's published figures. An IR release dated 02/27/2025 outlines the details.
Management highlighted continued organic growth in core markets and contributions from bolt-on acquisitions, while also pointing to a still-normalizing demand environment after the post-pandemic catch-up in hearing-aid fittings. Net profit improved, supported by operating leverage and cost control.
Analyst consensus into the next earnings
Market data providers compile a consensus that sees Amplifon delivering further moderate revenue growth and a gradual margin uptick over the next 12 to 18 months, based on estimates from a broad analyst group. Consensus snapshots on financial portals summarize these projections.
Several large banks and brokerages rate the stock between Hold and Buy, often citing the resilient demand for hearing-care services and the company's global scale, but also noting valuation that already prices in steady mid-single-digit growth.
Earnings calendar and investor focus
Based on the typical reporting rhythm and published financial calendar, Amplifon is expected to update the market on its next half-year or quarterly figures around late summer, though an exact 2026 date has not yet been formally confirmed on the IR site.
Until a firm date and fresh numbers are available, investors are likely to track trading updates, sector data points and any M&A moves, as these can shift growth expectations for the next reporting periods.
How the company makes money
Amplifon generates most of its revenue by selling and servicing hearing aids and related hearing-care solutions through a global network of specialist retail outlets and partnerships. The group earns from product sales, fitting services, after-care and accessories for its customers.
Where the stock trades today
The shares of Amplifon (IT0004056880) trade on Borsa Italiana in Milan at EUR 32.40 as of 06/22/2026, 14:20 CET.
Key facts on Amplifon stock
- Company: Amplifon S.p.A.
- ISIN: IT0004056880
- WKN: A2AB9Y
- Ticker: AMP
- Venue: Borsa Italiana
- Price (as of 06/22/2026, 14:20 CET): 32.40 EUR
- Market cap: 7,90 billion EUR (as of 06/22/2026)
- Sector / Industry: Health Care / Health Care Services
- Index membership: FTSE MIB
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
